Cue Biopharma, Inc. (CUE)
27.04
-1.40
(-4.92%)
USD |
NASDAQ |
Sep 02, 13:15
Cue Biopharma Research and Development Expense (Annual) : 37.43M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 37.43M |
| December 31, 2024 | 35.93M |
| December 31, 2023 | 40.28M |
| December 31, 2022 | 37.76M |
| December 31, 2021 | 40.19M |
| December 31, 2020 | 32.59M |
| Date | Value |
|---|---|
| December 31, 2019 | 26.60M |
| December 31, 2018 | 27.82M |
| December 31, 2017 | 18.50M |
| December 31, 2016 | 5.490M |
| December 31, 2015 | 1.460M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| Fortress Biotech, Inc. | 11.90M |
| Equillium, Inc. | 12.84M |
| Legend Biotech Corp. | 415.80M |
| Nurix Therapeutics, Inc. | 308.16M |